share_log

泰格医药(03347.HK)4月25日举行董事会会议审议及批准一季度报告

Tiger Pharmaceuticals (03347.HK) held a board meeting on April 25 to review and approve the first quarter report

Gelonghui Finance ·  Apr 15 04:31

Gelonghui, April 15, 丨 Tiger Pharmaceuticals (03347.HK) announced that the board meeting will be held on April 25, 2024 (Thursday) to review and approve (among other things) the first quarter reports of the company and its subsidiaries for the three months ended March 31, 2024 and/or other issues (if applicable).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment